Glucose Control Therapies


 2020-03-24

This resource on Type 1 Diabetes Research was created in partnership with JDRF, an active partner of Beyond Type 1 at the time of publication, through the JDRF – Beyond Type 1 Alliance.


Finding simpler and more advanced ways to help people living with type 1 diabetes control their blood glucose levels is one of the best ways to improve lives today. With recent advances in technology, approval of hybrid-closed loop systems and new drug classes being investigated, there has never been a better time to have diabetes. Glucose control therapy research focuses three core areas:

  • Artificial pancreas (AP) technologies such as the recently approved Control-IQ from Tandem Diabetes Care
  • Next-generation insulin classes such as ultra-fast insulin, and “smart” insulin that can automatically react to the changes in the blood glucose levels
  • Investigation into other drug classes such as SGLT inhibitors to improve blood glucose management

Helping people with type 1 diabetes (T1D) manage their blood glucose levels not only lowers the risk for future complications, it makes every day easier to get through without constantly worrying about your numbers!

Glucose Control Therapies: The Latest News

Tandem’s Control-IQ Hybrid Closed Loop Approved by the FDA


The FDA announced the approval of the Control-IQ Hybrid Closed Loop System from Tandem Diabetes Care. The system sees the t:slim X2 insulin pump and Dexcom G6 continuous glucose monitor working togeth...MORE

Glucose Control Therapies: Trials


To learn more about all the great T1D research being funded by JDRF, visit their research and impact page here.

WRITTEN BY BT1 Editorial Team, POSTED 03/24/20, UPDATED 01/03/23

This piece was authored collaboratively by the Beyond Type 1 Editorial Team.